Dr. Judah Folkman, the Boston researcher who discovered that the growth of tumors could be halted by cutting off their blood supply, has died at the age of 74.
Folkman, director of the vascular research program at Children's Hospital and a professor at Harvard Medical School, suffered an apparent heart attack Monday night, The Boston Globe reported.
While scientists took a long time to accept Folkman's work, his research has now led to a new generation of anti-cancer drugs, the report said. Pharmaceutical companies are testing angiogenesis inhibitors that have been proved to extend the lives of patients with advanced cancers.
Folkman was known for his modesty and was reluctant to claim credit for a cancer "cure."
"We never use the word 'cure' because it is far away," Folkman said not long before his death. "It may be that patients will have little tiny cancers that lie dormant for a long time."
A native of Cleveland, Folkman graduated from Ohio State University and Harvard Medical School. He spent most of his professional life in Boston.
Copyright 2008 by United Press International
Related stories:
Nanomaterials Key to New Strategies for Blocking Metastasis
A new treatment strategy using targeted nanoparticles to block metastasis with anti-cancer drugs leads to good results using significantly lower doses of toxic chemotherapy, with less collateral damage to surrounding tissue, according to a collaborative team of researchers at the Center of Nanotechnology for Treatment, Understanding, and Monitoring of Cancer at the University of California, San Diego. In designing this system, the investigators, led by David Cheresh, Ph.D., have identified what may become a generic method for using nanotechnology to target metastasis.
New treatment for age-related macular degeneration within sight
With 8 million people at high risk for advanced age-related macular degeneration, researchers from Harvard and Japan discovered that the experimental drug, endostatin, may be the cure. A research report published in the December 2007 issue of The FASEB Journal, describes how giving endostatin to mice significantly reduced or eliminated abnormal blood vessel growth within the eye, which is ultimately why the disease causes blindness.
Immune cells promote blood vessel formation in mouse endometriosis
A discovery in mice of immune cells that promote the formation of new blood vessels could lead to new treatments for endometriosis, a painful condition associated with infertility that affects up to 15 percent of women of reproductive age.
Normalizing tumor vessels to improve cancer therapy
Chemotherapy drugs often never reach the tumors they're intended to treat, and radiation therapy is not always effective, because the blood vessels feeding the tumors are abnormal—"leaky and twisty" in the words of the late Judah Folkman, MD, founder of the Vascular Biology program at Children's Hospital Boston.
MIT engineers an anti-cancer smart bomb
Imagine a cancer drug that can burrow into a tumor, seal the exits and detonate a lethal dose of anti-cancer toxins, all while leaving healthy cells unscathed. MIT researchers have designed a nanoparticle to do just that.